EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.11.16 | medicine | chemotherapeutic target, involved in heart disease, metastasis, inflammation | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.11.16 | amastatin | 100% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | arphamenine A | 50% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | Arphamenine B | 7% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | bestatin | some of the observed chemotherapeutic actions of bestatin may be due to inhibition of enzyme | Homo sapiens | |
3.4.11.16 | bestatin | 89% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | captopril | 56% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | cilazaprilat | 27% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | lisinopril | 28% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | pentoprilat | 27% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | probestin | % inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | rentiapril | 100% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | spiraprilat | 28% inhibition at 0.1 mM | Sus scrofa | |
3.4.11.16 | zofenoprilat | 82% inhibition at 0.1 mM | Sus scrofa |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.11.16 | Homo sapiens | - |
- |
- |
3.4.11.16 | Sus scrofa | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.11.16 | kidney | - |
Sus scrofa | - |